Founded Date: 2014
Technology: Neurological Disorders
Investor Type: Company
Funding Status: Early Stage Venture
Total Funding: €27.1M
Employee Number: 11-50
Headquarters: Paris, Ile-de-France, France
Investors Number: 9
Last Funding Type: Series B
Estimated Revenue: $1M to $10M
Investment Stage: N/A
Number Of Exists: Series B
Industry: Gene Therapy